Patriot Financial Group Insurance Agency, LLC Exelixis, Inc. Transaction History

Patriot Financial Group Insurance Agency, LLC

$720 Million
Q3 2024

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 17, 2023	BUY	$14.96 - $17.39 $18,326 - $21,302	1,225 Added 3.37%	37,524 $0
Q3 2022 Oct 31, 2022	BUY	$15.68 - $22.27 $28,537 - $40,531	1,820 Added 5.28%	36,299 $569,000
Q2 2022 Jul 29, 2022	SELL	$17.44 - $23.16 $61,040 - $81,060	-3,500 Reduced 9.22%	34,479 $718,000
Q1 2022 May 11, 2022	SELL	$17.03 - $22.67 $13,385 - $17,818	-786 Reduced 2.03%	37,979 $861,000
Q4 2021 Jan 10, 2022	BUY	$15.84 - $21.88 $39,600 - $54,700	2,500 Added 6.89%	38,765 $709,000
Q3 2021 Nov 24, 2021	BUY	$16.3 - $21.14 $50,839 - $65,935	3,119 Added 9.41%	36,265 $767,000
Q2 2021 Jul 30, 2021	SELL	$17.95 - $25.56 $5,869 - $8,358	-327 Reduced 0.98%	33,146 $604,000
Q1 2021 Apr 29, 2021	BUY	$20.53 - $25.22 $84,193 - $103,427	4,101 Added 13.96%	33,473 $756,000
Q4 2020 Jan 15, 2021	BUY	$18.39 - $24.8 $507,508 - $684,405	27,597 Added 1554.76%	29,372 $589,000
Q3 2020 Oct 21, 2020	SELL	$20.67 - $26.94 $20,670 - $26,940	-1,000 Reduced 36.04%	1,775 $43,000
Q4 2019 Jan 22, 2020	SELL	$15.15 - $18.89 $10,605 - $13,223	-700 Reduced 20.14%	2,775 $49,000
Q3 2019 Oct 25, 2019	SELL	$17.68 - $22.65 $38,012 - $48,697	-2,150 Reduced 38.22%	3,475 $61,000
Q2 2019 Aug 07, 2019	BUY	$18.93 - $24.75 $106,481 - $139,218	5,625 New	5,625 $119,000

Others Institutions Holding EXEL

# of Institutions

503

Shares Held

244M

Call Options Held

2.54M

Put Options Held

2.29M

Black Rock Inc. New York, NY

33.5M
Shares

$1.2 Billion
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

29.3M
Shares

$1.05 Billion
0.01% of portfolio
Farallon Capital Management LLC San Francisco, CA

25.4M
Shares

$913 Million
3.31% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

15.4M
Shares

$552 Million
0.63% of portfolio
State Street Corp Boston, MA

11.4M
Shares

$411 Million
0.01% of portfolio

View Full List

About EXELIXIS, INC.

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $11.6B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

More about EXEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Patriot Financial Group Insurance Agency, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Patriot Financial Group Insurance Agency, LLC with notifications on news.

Account